You've been right all along Jess, In the beginning I wish I had listened to you instead of being at odds with you, That mistake cost me all the profits I had made on Bgmd the year before. As for the current share price, As you and I have said many times before, There will be no sales IF ANY till mid 2016, and again you WILL be right IMO that they will have to do more funding, problem is how are they going to get that while trading under a dollar, If they do funding under a buck , it'll be costly to shareholders, GL Jess
THIS CO. IS A POS
They must think the voting will be tight, hmmmmm
I was gonna get in but not now
This would be dropping and forming a new base to start another run, But it seems to be holding the .05's - 06's, Which is above the base I would have thought. Anyway I've got it on my watch list and if it continues to trade here , I'll take a position.
there is NO pre or after market trades in OTC stocks, what those are is the MM booking trades that were not booked in the open market, so nobody missed out on anything,
The $20M Grant along with existing cash will fund the the entire P3, esident and Chief Executive Officer. "We are excited to be close to initiating our phase 3 registration trial. With this important grant of non-dilutive capital and our current cash, we are in position to cover the full external cost of conducting the trial and ensure high quality trial execution. Our strategic focus going forward will be on advancing our Stem-to-T-cell immunotherapy platform and pursuing additional related technologies to grow our pipeline – strategies that are key to achieving our goal of building a leading cancer immunotherapy company."
First of all , They DONT need the money, They have enough cash $27M and grant money $20M to last 3 to 4 years with a burn rate of $9M per year.
If you would read the last 8K about Dr. Yu's resignation You'll see this statement ,"" Dr. Yu will provide consulting services to the Company, including supporting the execution of the phase 3 clinical trial of ICT-107 and assisting with the evaluation and acquisition of outside technology. "" IMO they are about to do an acquisition ""
From DEF 14A Filing last week "" such shares may be needed in the future in connection with acquiring another company or its business or assets, establishing a strategic relationship with a corporate partner ""
I could see them putting that statement in the DEF 14A as that is IMO also a boiler plate statement, But to also add that to Dr. Yu's resignation statement makes no sense at all, Unless of course they are about to do an acquisition ,Think about it, What does the mention of " assisting with the evaluation and acquisition of outside technology. " have to do with Dr. Yu resigning, The answer is Nothing, So why include it ???
OH BTW, Dr Yu Is only with the company till Dec.31 2015, So IF this goes down as I think it Will, It'll be done by that date. Its all food for thought and trying to connect the dots.
"" Isn't it just going to dilute the existing shares? "" No its NOT, Unless they are issued, Increasing the authorized shares is in no means Issuing those shares .
"" the proposal could have a "dilutive effect" on existing shares. "" That is a boiler plate statement included in any filing asking to raise the share count ""
You're right on that Mitch, MM has its way with that stock and wont turn it loose, It'll brake out with the P3 coming into play soon, Just hope it holds up, Its got 3 to 4 years without having to raise more cash which is a BIG plus, But if you've got weak hands, Its not for you. GL Today
They is going into P3 within weeks . No debt . $50M Cash and Grant money with a burn rate of $9M a year and still went down
Let us not forget that recent board member Mark A. Schlossberg currently serves as Senior Vice President, General Counsel and Corporate Secretary of Impax Laboratories, Inc., where he is part of the senior management team responsible for the strategic direction and financial condition of the company. He leads the legal team and previously had responsibility for the healthcare compliance team. Prior to Impax, he served as Vice President, Associate General Counsel of Amgen Inc., where he led the legal department, and was responsible for corporate governance, securities law, licensing,(((( mergers and acquisitions, )))) global operations, and sales and marketing compliance. Prior to joining Amgen, he held legal and business positions at Medtronic, Inc.
Now the question is, When Dr. Yu leaves will we be Out Of compliance with the NYSE again because of the departure of Dr.Yu , As was the case on Sept 22 with the appointments of 2 Directors ????
(( The appointment of Mr. Schlossberg and Mr. Lapointe as independent members of the Company's Board of Directors enables ImmunoCellular to regain compliance with the listing standards of the New York Stock Exchange MKT regarding the majority of independent directors' requirement as well as having at least three independent directors serving on the Audit Committee. ))
Sorry, Forgot to include this , "" Name and Address of Beneficial Owner. John S. Yu, M.D. Shares
Beneficially Owned 6,422,576 6.65 % ""
"" Includes 6,422,576 shares of our common stock underlying stock options that are exercisable within 60 days of September 15, 2015.""
You may never know that answer, IMO, If they asked him to resign, It would have taken effect immediately, On the other hand he was Founder, Chairman, Chief Scientific Officer and Corp. Sec. and made $220K yearly, CEO made $533K, So he was not the top dog in this show.
From DEF 14A , Name and Address of Beneficial Owner. John S. Yu, M.D. Shares
Beneficially Owned 6,422,576 6.65 %
If he starts selling those shares, You'll get your answer
"" Dr. Yu will provide consulting services to the Company, including supporting the execution of the phase 3 clinical trial of ICT-107 and assisting with the evaluation and acquisition of outside technology. Dr. Yu will receive a fee of $11,103 per month. The term of the Agreement expires on December 31, 2015, ""
It seems Dr. Yu is staying just long enough to see the execution of the phase 3 clinical trial of ICT-107, Which by the way is due any week now, This news was known by the Company on Oct 1st the day Dr. Yu filed his form 4's.
The Company also filed their DEF 14A the other day and are increasing their authorized number of shares of common stock from 149,000,000 to 249,000,000, From the DEF 14A "" establishing strategic relationships with other companies; expanding the Company’s business or product lines through the acquisition of other businesses or products; and other purposes. "" They have mentioned a few times in past filings that they are looking at the " evaluation and acquisition of outside technology " and in this filing they mention the same line and say " Dr. Yu will assist with the evaluation and acquisition of outside technology " Seeing that he's leaving by Dec. 31st 2015, That'll give you food for thought !!!!
So true, So true, he keep on buying small cap stocks without doing DD, He'll find out soon that he's made a bad trade in a bad stock, And find that the stock has fallen and it cant get up.
I would much rather be in a stock like this that has cash and grant money for at least 3 years and finish Ph3, No Debt, Nice pipeline and plenty of support. Good Luck Robert, You'll need it.
Sentiment: Strong Buy
To be honest, This price has more to do with it being under .50, It can be highly manipulated at this price, I wouldn't pay to much attention to it if you already own the stock. They have cash and grant money of around $50M , Enough for them to complete Ph. 3 Trials, And that may also be part of the problem, Ph 3 will take years and the shorts know that, Hence the current share price. Good Luck
I know you've said you were at one time a market maker, believe me , this was a play by shorts and the market maker took full advantage of the situation, this was a bear raid and the MM let it happen for obvious reasons, he'll be pumping the price up at some point and dump his position. As for someone knowing something, If they do know something, they know that this is fully funded for at least 3 - 4 years, no problems there, full funding for Ph 3 to completion, DELISTING issue solved, So what's the problem, Daytraders that's what, they panicked on Friday because they haven't done their DD and the bear raid came in and finished them off , With the help of the MM, you've got to have strong hands and know what you're buying, give it time, I think this time is a charm.
You can be darn sure they'll be selling those shares on monday for a nice profit, rinse and repeat